Director of API retires

By Dylan Bushell-Embling
Thursday, 10 July, 2008

A director of Australian Pharmaceutical Industries [ASX: API], Barry Frost, announced his retirement today.

Frost has served on the company's board since 1993, and has been deputy chairman since 2001. His resignation will be effective July 31.

API, which markets and distributes prescription and over-the-counter medications, has announced that it is currently looking for replacement for the position.

mRNA successfully delivered through blood–brain barrier

Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic...

Biological computer could revolutionise medical sciences

The CL1 is a commercial biological computer which fuses lab-cultivated neurons from human stem...

Genetic risk of schizophrenia impacts men and women differently

Men tend to present different clinical symptoms from women, poorer premorbid functioning and...

Content from other channels on our network

Universities and AMRF partner to boost advanced manufacturing in NSW

Australian Made Campaign to receive funding boost

OFS launches AI‍-‍based productivity solution for manufacturing

Researchers developing automated electronics disassembly

Western Sydney forum aims to help manufacturers stay competitive

A mango a day could keep the doctor away

The impact of global warming on food security

How 'wizards' are helping winemakers

Baskin-Robbins launches 'deceptive' dessert range

Pure Dairy announces leadership and facility plans

Australia invests in manufacturing capability for IV fluids

'Natural killer' cells target paediatric sarcomas

Healthcare jobs rising: key learnings from a job site's data

AdPha releases strategic plan towards 'pharmacy in 2030'

Nominations are open for Australia's nursing trailblazers